Geode Capital Management
OCEA

Geode Capital Management’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Geode Capital Management’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-161,571
Closed -$8.73K – 4554
2025
Q1 		$8.73K Sell
161,571
-13,737
-8% -$3.28K ﹤0.01% 4437
2024
Q4 		$97K Buy
175,308
+34,317
+24% +$27K ﹤0.01% 4105
2024
Q3 		$138K Sell
140,991
-1,910
-1% -$2.05K ﹤0.01% 4016
2024
Q2 		$174K Sell
142,901
-90,547
-39% -$154K ﹤0.01% 3964
2024
Q1 		$884K Sell
233,448
-5,624
-2% -$10.6K ﹤0.01% 3409
2023
Q4 		$158K Buy
239,072
+4,018
+2% +$5.51K ﹤0.01% 4020
2023
Q3 		$917K Buy
235,054
+607
+0.3% +$2.79K ﹤0.01% 3361
2023
Q2 		$1.41M Buy
234,447
+171,742
+274% +$1.01M ﹤0.01% 3225
2023
Q1 		$416K Buy
+62,705
New +$530K ﹤0.01% 3712

Other funds holding OCEA

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VPIM
Vanguard Personalized Indexing Management Oakland, California $10.2B AUM 34.45% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
SMA
Sage Mountain Advisors Atlanta, Georgia $1.43B AUM 16.47% 1-Year Est. Return

Geode Capital Management's OCEA Position: Q2 2025 in Review

Geode Capital Management sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q2 2025, closing a stake of 161,571 shares — an estimated $8.73K sold.

Geode Capital Management first reported a position in OCEA in Q1 2023 and held it in 9 quarters. The position peaked at $1.41M in Q2 2023. 7 funds tracked by Wall St. Rank hold OCEA as of Q2 2025.

  • Geode Capital Management reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
  • Geode Capital Management sold 161,571 Ocean Biomedical, Inc. Common Stock shares in Q2 2025, an estimated $8.73K.
  • Geode Capital Management first reported a position in Ocean Biomedical, Inc. Common Stock in Q1 2023 and held it in 9 quarters.
  • Geode Capital Management's Ocean Biomedical, Inc. Common Stock position peaked at $1.41M in Q2 2023.
  • 7 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q2 2025.

Based on Geode Capital Management's 13F filing for Q2 2025, filed 8 Aug 2025.